发明授权
US08513248B2 5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine derivatives as P2X7 modulators
有权
5,6,7,8-四氢咪唑并[1,2-A]吡嗪衍生物作为P2X7调节剂
- 专利标题: 5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine derivatives as P2X7 modulators
- 专利标题(中): 5,6,7,8-四氢咪唑并[1,2-A]吡嗪衍生物作为P2X7调节剂
-
申请号: US13266557申请日: 2010-04-28
-
公开(公告)号: US08513248B2公开(公告)日: 2013-08-20
- 发明人: David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Ian David Wall , Daryl Simon Walter
- 申请人: David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Ian David Wall , Daryl Simon Walter
- 申请人地址: GB Greenford, Middlesex
- 专利权人: Glaxo Group Limited
- 当前专利权人: Glaxo Group Limited
- 当前专利权人地址: GB Greenford, Middlesex
- 代理商 Nora L. Stein; Theodore R. Furman
- 优先权: GB0907515.1 20090430
- 国际申请: PCT/EP2010/055714 WO 20100428
- 国际公布: WO2010/125101 WO 20101104
- 主分类号: A61K31/495
- IPC分类号: A61K31/495
摘要:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2fluoroalkyl, halogen, NR6R7, optionally substituted heteroaryl (Het), or optionally substituted phenyl, and R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The compounds or salts are thought to modulate P2X7 receptor function and to be capable of antagonizing the effects of ATP at the P2X7 receptor. The invention also provides the use of the compound or salt in the treatment or prophylaxis of, for example, inflammatory pain, neuropathic pain, visceral pain, rheumatoid arthritis or osteoarthritis or neurodegenerative disorders.
公开/授权文献
信息查询